Does cigarette smoking increase plasma urotensin II concentrations?

European Journal of Clinical Pharmacology

Volumn 63, Issue 3, 2007, Pages 253-257

  Gold, S J ^a   Thompson, J P ^a   Williams, J P ^a   Helm, E E F ^a   Sadler, J ^a   Song, W ^a   Ng, L L ^a   Lambert, D G ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Plasma; Smoking; Urotensin II

Indexed keywords

UROTENSIN II;

ADULT; ARTICLE; ASSAY; BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; IMMUNOLUMINOMETRIC ASSAY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

ADULT; HUMANS; LUMINESCENT MEASUREMENTS; MALE; MIDDLE AGED; RADIOIMMUNOASSAY; SMOKING; UROTENSINS;

EID: 33846940522     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-006-0252-6     Document Type: Article

References (31)

1. Bern HA, Lederis K (1969) A reference preparation for the study of bioactive substances in the caudal neurosecretory system of teleosts. J Endocrinol 45(Suppl):xi-xii
2. Ames RS, Sarau HM, Chambers JK, Willette RN, Aiyar NV, Romanic AM, Louden CS, Foley JJ, Sauermelch CF, Coatney RW, Ao Z, Disa J, Holmes SD, Stadel JM, Martin JD, Liu WS, Glover GI, Wilson S, McNulty DE, Ellis CE, Elshourbagy NA, Shabon U, Trill JJ, Hay DW, Douglas SA (1999) Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 401:282-286
3. Maguire JJ, Kuc RE, Davenport AP (2000) Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1. Br J Pharmacol 131:441-446
4. Katano Y, Ishihata A, Aita T, Ogaki T, Horie T (2000) Vasodilator effect of urotensin II, one of the most potent vasoconstricting factors, on rat coronary arteries. Eur J Pharmacol 402:R5-R7
5. Davenport AP, Maguire JJ (2000) Urotensin II: fish neuropeptide catches orphan receptor. Trends Pharmacol Sci 21:80-82
6. Douglas SA, Ohlstein EH (2000) Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease. Trends Cardiovasc Med 10:229-237
7. Maguire JJ, Davenport AP (2002) Is urotensin-II the new endothelin? Br J Pharmacol 137:579-588
8. Onan D, Hannan RD, Thomas WG (2004) Urotensin II: the old kid in town. Trends Endocrinol Metab 15:175-182
9. Douglas SA (2003) Human urotensin-II as a novel cardiovascular target: 'heart' of the matter or simply a fishy 'tail'? Curr Opin Pharmacol 3:159-167
10. Gilbert RE, Douglas SA, Krum H (2004) Urotensin-II as a novel therapeutic target in the clinical management of cardiorenal disease. Curr Opin Invest Drugs 5:276-282
11. Douglas SA, Dhanak D, Johns DG (2004) From 'gills to pills': urotensin-II as a regulator of mammalian cardiorenal function. Trends Pharmacol Sci 25:76-85
12. Doggrell SA (2004) Urotensin-II and the cardiovascular system-the importance of developing modulators. Expert Opin Invest Drugs 13:479-487
13. Ng LL, Loke I, O'Brien RJ, Squire IB, Davies JE (2002) Plasma urotensin in human systolic heart failure. Circulation 106:2877-2880
14. Totsune K, Takahashi K, Arihara Z, Sone M, Satoh F, Ito S, Kimura Y, Sasano H, Murakami O (2001) Role of urotensin II in patients on dialysis. Lancet 358:810-811
15. Totsune K, Takahashi K, Arihara Z, Sone M, Ito S, Murakami O (2003) Increased plasma urotensin II levels in patients with diabetes mellitus. Clin Sci (Lond) 104:1-5
16. Matsushita M, Shichiri M, Imai T, Iwashina M, Tanaka H, Takasu N, Hirata Y (2001) Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues. J Hypertens 19:2185-2190
17. Ong KL, Lam KS, Cheung BM (2005) Urotensin II: its function in health and its role in disease. Cardiovasc Drugs Ther 19:65-75
18. Benowitz NL (1988) Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med 319:1318-1330
19. Salonen JT, Salonen R (1990) Association of serum low density lipoprotein cholesterol, smoking and hypertension with different manifestations of atherosclerosis. Int J Epidemiol 19:911-917
20. Thompson JP, Watt P, Sanghavi S, Strupish JW, Lambert DG (2003) A comparison of cerebrospinal fluid and plasma urotensin II concentrations in normotensive and hypertensive patients undergoing urological surgery during spinal anesthesia: a pilot study. Anesth Analg 97:1501-1503
21. Cowley E, Thompson JP, Sharpe P, Waugh J, Ali N, Lambert DG (2005) Effects of pre-eclampsia on maternal plasma, cerebrospinal fluid, and umbilical cord urotensin II concentrations: a pilot study. Br J Anaesth 95:495-499
22. Ng LL, O'Brien RJ, Demme B, Jennings S (2002) Non-competitive immunochemiluminometric assay for cardiotrophin-1 detects elevated plasma levels in human heart failure. Clin Sci (Lond) 102:411-416
23. Mori M, Fujino M (2004) Urotensin II-related peptide, the endogenous ligand for the urotensin II receptor in the rat brain. Peptides 25:1815-1818
24. Sondermeijer B, Kompa A, Komesaroff P, Krum H (2005) Effect of exogenous urotensin-II on vascular tone in skin microcirculation of patients with essential hypertension. Am J Hypertens 18:1195-1199
25. Lim M, Honisett S, Sparkes CD, Komesaroff P, Kompa A, Krum H (2004) Differential effect of urotensin II on vascular tone in normal subjects and patients with chronic heart failure. Circulation 109:1212-1214
26. Watson AM, Lambert GW, Smith KJ, May CN (2003) Urotensin II acts centrally to increase epinephrine and ACTH release and cause potent inotropic and chronotropic actions. Hypertension 42:373-379
27. Hood SG, Watson AM, May CN (2005) Cardiac actions of central but not peripheral urotensin II are prevented by beta-adrenoceptor blockade. Peptides 26:1248-1256
28. Lin Y, Tsuchihashi T, Matsumura K, Abe I, Iida M (2003) Central cardiovascular action of urotensin II in conscious rats. J Hypertens 21:159-165
29. Horie S, Tsurumaki Y, Someya A, Hirabayashi T, Saito T, Okuma Y, Nomura Y, Murayama T (2005) Involvement of cyclooxygenase-dependent pathway in contraction of isolated ileum by urotensin II. Peptides 26:323-329
30. Baer L, Radichevich I (1985) Cigarette smoking in hypertensive patients. Blood pressure and endocrine responses. Am J Med 78:564-568
31. Letizia C, Cerci S, Subioli S, Scuro L, Clemente G (1997) Increased plasma endothelin-1 after nicotine consumption in nonsmokers. Clin Chem 43:2440-2441